These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 18362898)

  • 1. Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.
    Elliott S
    Br J Pharmacol; 2008 Jun; 154(3):529-41. PubMed ID: 18362898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and erythropoiesis stimulating agents.
    Debeljak N; Sytkowski AJ
    Drug Test Anal; 2012 Nov; 4(11):805-12. PubMed ID: 22508651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous Doping with Cryopreserved Red Blood Cells - Effects on Physical Performance and Detection by Multivariate Statistics.
    Malm CB; Khoo NS; Granlund I; Lindstedt E; Hult A
    PLoS One; 2016; 11(6):e0156157. PubMed ID: 27284981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen delivery enhancers: past, present, and future.
    Borrione P; Mastrone A; Salvo RA; Spaccamiglio A; Grasso L; Angeli A
    J Endocrinol Invest; 2008 Feb; 31(2):185-92. PubMed ID: 18362513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring recombinant human erythropoietin abuse among athletes.
    Citartan M; Gopinath SCB; Chen Y; Lakshmipriya T; Tang TH
    Biosens Bioelectron; 2015 Jan; 63():86-98. PubMed ID: 25058943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoiesis-stimulating agents: development, detection and dangers.
    Franz SE
    Drug Test Anal; 2009 Jun; 1(6):245-9. PubMed ID: 20355203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biochemistry of drugs and doping methods used to enhance aerobic sport performance.
    Cooper CE
    Essays Biochem; 2008; 44():63-83. PubMed ID: 18384283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin.
    Jelkmann W
    Front Horm Res; 2016; 47():115-27. PubMed ID: 27348128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future.
    Leuenberger N; Reichel C; Lasne F
    Bioanalysis; 2012 Jul; 4(13):1565-75. PubMed ID: 22831473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood doping: risks to athletes' health and strategies for detection.
    Oliveira CD; Bairros AV; Yonamine M
    Subst Use Misuse; 2014 Jul; 49(9):1168-81. PubMed ID: 24766400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sports drug testing for erythropoiesis-stimulating agents and autologous blood transfusion.
    Reichel C
    Drug Test Anal; 2012 Nov; 4(11):803-4. PubMed ID: 22927317
    [No Abstract]   [Full Text] [Related]  

  • 12. Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry.
    Yu NH; Ho EN; Wan TS; Wong AS
    Anal Bioanal Chem; 2010 Apr; 396(7):2513-21. PubMed ID: 20148243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant erythropoietin and analogues: a challenge for doping control.
    Pascual JA; Belalcazar V; de Bolos C; Gutiérrez R; Llop E; Segura J
    Ther Drug Monit; 2004 Apr; 26(2):175-9. PubMed ID: 15228161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples.
    Leuenberger N; Saugy J; Mortensen RB; Schatz PJ; Giraud S; Saugy M
    Forensic Sci Int; 2011 Dec; 213(1-3):15-9. PubMed ID: 21816551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin as a performance-enhancing drug: Its mechanistic basis, detection, and potential adverse effects.
    Salamin O; Kuuranne T; Saugy M; Leuenberger N
    Mol Cell Endocrinol; 2018 Mar; 464():75-87. PubMed ID: 28119134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oxygen blood transport and doping].
    Audran M; Connes P; Varlet-Marie E
    Bull Acad Natl Med; 2003; 187(9):1669-79; discussion 1680-3. PubMed ID: 15369237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for increasing oxygen and their potential use in doping: a review.
    Gaudard A; Varlet-Marie E; Bressolle F; Audran M
    Sports Med; 2003; 33(3):187-212. PubMed ID: 12656640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel serum biomarkers for erythropoietin use in humans: a proteomic approach.
    Christensen B; Sackmann-Sala L; Cruz-Topete D; Jørgensen JO; Jessen N; Lundby C; Kopchick JJ
    J Appl Physiol (1985); 2011 Jan; 110(1):149-56. PubMed ID: 20966191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting doping use: more than an analytical problem.
    Delanghe JR; Maenhout TM; Speeckaert MM; De Buyzere ML
    Acta Clin Belg; 2014; 69(1):25-9. PubMed ID: 24635395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.
    Wilber RL
    Sports Med; 2002; 32(2):125-42. PubMed ID: 11817997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.